AXP vs TTRX · P/E 20, rev $21.73B vs $187.1M cap
American Express Company (AXP) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
TTRX does not have a complete income-statement cache yet.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the AXP and TTRX stock pages for the full models.
Not investment advice.